EMFO LLC’s AstraZeneca AZN Stock Holding History

EMFO LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$46.8K	Hold	300	–	–	0.04%	158
2024 Q1	$40.6K	Hold	300	–	–	0.04%	159
2023 Q4	$40.4K	Hold	300	–	–	0.04%	160
2023 Q3	$40.6K	Hold	300	–	–	0.04%	168
2023 Q2	$42.9K	Hold	300	–	–	0.04%	175
2023 Q1	$41.6K	Hold	300	–	–	0.04%	174
2022 Q4	$40.7K	Hold	300	–	–	0.04%	165
2022 Q3	$33K	Hold	300	–	–	0.03%	194
2022 Q2	$40K	Hold	300	–	–	0.04%	191
2022 Q1	$40K	Hold	300	–	–	0.04%	199
2021 Q4	$35K	Hold	300	–	–	0.03%	217
2021 Q3	$36K	Buy	+300	New	+$34.9K	0.03%	225

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EMFO LLC's AZN Position: Q2 2024 in Review

EMFO LLC held its AstraZeneca (AZN) position steady in Q2 2024 at 300 shares worth $46.8K. The position accounts for 0.04% of the portfolio, ranked #158.

EMFO LLC first reported a position in AZN in Q3 2021 and has held it in 12 quarters since. 1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

EMFO LLC held 300 shares of AstraZeneca worth $46.8K as of Q2 2024.
EMFO LLC left its AstraZeneca share count unchanged in Q2 2024.
AstraZeneca made up 0.04% of EMFO LLC's portfolio in Q2 2024, its #158 holding.
EMFO LLC first reported a position in AstraZeneca in Q3 2021 and has held it in 12 quarters since.
1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.